These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32902733)

  • 1. Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson's disease: does the levodopa overdose hypothesis extend to gait?
    Dagan M; Herman T; Bernad-Elazari H; Gazit E; Maidan I; Giladi N; Mirelman A; Manor B; Hausdorff JM
    J Neurol; 2021 Feb; 268(2):658-668. PubMed ID: 32902733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa Facilitates Prefrontal Cortex Activation During Dual Task Walking in Parkinson Disease.
    Orcioli-Silva D; Vitório R; Nóbrega-Sousa P; da Conceição NR; Beretta VS; Lirani-Silva E; Gobbi LTB
    Neurorehabil Neural Repair; 2020 Jul; 34(7):589-599. PubMed ID: 32449460
    [No Abstract]   [Full Text] [Related]  

  • 3. Prefrontal Cortex Activity and Gait in Parkinson's Disease With Cholinergic and Dopaminergic Therapy.
    Stuart S; Morris R; Giritharan A; Quinn J; Nutt JG; Mancini M
    Mov Disord; 2020 Nov; 35(11):2019-2027. PubMed ID: 32830901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive Control of Walking in People With Parkinson's Disease With Freezing of Gait.
    Vitorio R; Stuart S; Mancini M
    Neurorehabil Neural Repair; 2020 Dec; 34(12):1138-1149. PubMed ID: 33155506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical Activity Underlying Gait Improvements Achieved With Dopaminergic Medication During Usual Walking and Obstacle Avoidance in Parkinson Disease.
    Orcioli-Silva D; Vitório R; Nóbrega-Sousa P; Beretta VS; Conceição NRD; Oliveira AS; Pereira MP; Gobbi LTB
    Neurorehabil Neural Repair; 2021 May; 35(5):406-418. PubMed ID: 33754884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural substrates of levodopa-responsive gait disorders and freezing in advanced Parkinson's disease: a kinesthetic imagery approach.
    Maillet A; Thobois S; Fraix V; Redouté J; Le Bars D; Lavenne F; Derost P; Durif F; Bloem BR; Krack P; Pollak P; Debû B
    Hum Brain Mapp; 2015 Mar; 36(3):959-80. PubMed ID: 25411130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in prefrontal cortical activity and turning in response to dopaminergic and cholinergic therapy in Parkinson's disease: A randomized cross-over trial.
    Vitorio R; Stuart S; Giritharan A; Quinn J; Nutt JG; Mancini M
    Parkinsonism Relat Disord; 2021 May; 86():10-14. PubMed ID: 33813359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Time Course of Changes in Prefrontal Cortex Activity During Walking in People With Parkinson's Disease.
    Silva-Batista C; Liu W; Vitorio R; Stuart S; Quinn JF; Mancini M
    Neurorehabil Neural Repair; 2024 Sep; 38(9):635-645. PubMed ID: 39075890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gait variability in Parkinson's disease: levodopa and walking direction.
    Bryant MS; Rintala DH; Hou JG; Collins RL; Protas EJ
    Acta Neurol Scand; 2016 Jul; 134(1):83-6. PubMed ID: 26399376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Short-Latency Afferent Inhibition in Parkinson's Disease Patients with L-dopa-Unresponsive Freezing of Gait.
    Wang L; Ji M; Sun H; Gan C; Zhang H; Cao X; Yuan Y; Zhang K
    J Parkinsons Dis; 2022; 12(8):2507-2518. PubMed ID: 36502341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association between Prefrontal Cortex Activity and Turning Behavior in People with and without Freezing of Gait.
    Belluscio V; Stuart S; Bergamini E; Vannozzi G; Mancini M
    Neuroscience; 2019 Sep; 416():168-176. PubMed ID: 31330231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of dopaminergic medication on gait automaticity in Parkinson's disease.
    Workman CD; Thrasher TA
    J Clin Neurosci; 2019 Jul; 65():71-76. PubMed ID: 30902437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa alters resting-state functional connectivity more selectively in Parkinson's disease with freezing of gait.
    Potvin-Desrochers A; Atri A; Moreno AM; Paquette C
    Eur J Neurosci; 2023 Jan; 57(1):163-177. PubMed ID: 36251568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources.
    Pieruccini-Faria F; Jones JA; Almeida QJ
    Neuroscience; 2016 Mar; 318():219-29. PubMed ID: 26794593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson's disease.
    McKay JL; Nye J; Goldstein FC; Sommerfeld B; Smith Y; Weinshenker D; Factor SA
    Neurobiol Dis; 2023 Apr; 179():106048. PubMed ID: 36813207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues.
    Rochester L; Baker K; Nieuwboer A; Burn D
    Mov Disord; 2011 Feb; 26(3):430-5. PubMed ID: 21462258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
    Kwon KY; Lee HM; Kang SH; Pyo SJ; Kim HJ; Koh SB
    Gait Posture; 2017 Oct; 58():1-6. PubMed ID: 28692855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of the Frontal Lobe in Complex Walking Among Patients With Parkinson's Disease and Healthy Older Adults: An fNIRS Study.
    Maidan I; Nieuwhof F; Bernad-Elazari H; Reelick MF; Bloem BR; Giladi N; Deutsch JE; Hausdorff JM; Claassen JA; Mirelman A
    Neurorehabil Neural Repair; 2016 Nov; 30(10):963-971. PubMed ID: 27221042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.
    Herz DM; Siebner HR; Hulme OJ; Florin E; Christensen MS; Timmermann L
    Neuroimage; 2014 Apr; 90():15-23. PubMed ID: 24269570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson's disease.
    Herman T; Dagan M; Shema-Shiratzky S; Reches T; Brozgol M; Giladi N; Manor B; Hausdorff JM
    J Neurol; 2020 Sep; 267(9):2582-2588. PubMed ID: 32383040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.